SCHEMBL32665089

SCHEMBL32665089

O=C1C=CC(=O)N1C1CC2(CCN(Cc3ccc(OS(=O)(=O)F)c(F)c3)CC2)C1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DOCK5 Q9H7D0 1/20 0.35
SCN9A Q15858 3/20 0.34
ALDH1A1 P00352 3/20 0.33
S1PR5 Q9H228 2/20 0.33
HTT P42858 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
S1PR1 P21453 1/20 0.33
SCN4A P35499 1/20 0.33
SCN5A Q14524 1/20 0.33
CXCR3 P49682 1/20 0.33
GPR183 P32249 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
DRD1 P21728 1/20 0.32
DRD3 P35462 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32
SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665432 0.92 NPSR1 (0.36) SCN9AALDH1A1HTTSCN4ASCN5A
SCHEMBL32665137 0.84 HRH3 (0.36) ALDH1A1LMNAMAPK1CXCR3
SCHEMBL32665508 0.83 CCR8 (0.39) ALDH1A1MAPK1CXCR3DRD3SIGMAR1
SCHEMBL32665176 0.79 STS (0.36) ALDH1A1MAPK1GPR183GPR119
SCHEMBL32665530 0.74 MGLL (0.47) ALDH1A1HTTLMNAMAPK1
SCHEMBL32665461 0.73 CYP2D6 (0.39) ALDH1A1LMNAMAPK1SIGMAR1
SCHEMBL32665031 0.73 HTR1A (0.38) ALDH1A1MAPK1
SCHEMBL32665228 0.72 CHRM2 (0.46) LMNADRD3SIGMAR1
SCHEMBL32665623 0.70 GSK3A (0.35) ALDH1A1MAPK1CXCR3
SCHEMBL32665268 0.70 CYP2C9 (0.33) SCN9AALDH1A1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A DOCK5 1416/4885SCN9A 3738/4885ALDH1A1 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.